BACKGROUND: Biochemical analysis of mutant huntingtin (mHTT) aggregation species in HD mice is a common measure to track disease. A longitudinal and systematic study of how tissue processing affects detection of conformers has not yet been reported. Understanding the homeostatic flux of mHTT over time and under different processing conditions would aid in interpretation of pre-clinical assessments of disease interventions. OBJECTIVE: Provide a systematic evaluation of tissue lysis methods and molecular and biochemical assays in parallel with behavioral readouts in R6/2 mice to establish a baseline for HTT exon1 protein accumulation. METHODS: Established biochemical methods were used to process tissue from R6/2 mice of specific ages following behavior tasks. Aggregation states and accumulation of mHTT exon 1 protein were evaluated using multiple break and assay methods to determine potential conformational flux assay specificity in detection of mHTT species, and tissue specificity of conformers. RESULTS: Detection of mHTT exon 1 protein species varied based on biochemical processing and analysis providing a baseline for subsequent studies in R6/2 mice. Insoluble, high molecular weight species of mHTT exon 1 protein increased and tracked with onset of behavioral impairments in R6/2 mice using multiple assay methods. CONCLUSIONS: Conformational flux from soluble monomer to high molecular weight, insoluble species of mHTT exon 1 protein was generally consistent for multiple assay methods throughout R6/2 disease progression; however, the results support the use of multiple biochemical techniques to detect mHTT exon 1 protein species for preclinical assessments in HD mouse models expressing mHTT exon 1 protein.
BACKGROUND: Biochemical analysis of mutant huntingtin (mHTT) aggregation species in HDmice is a common measure to track disease. A longitudinal and systematic study of how tissue processing affects detection of conformers has not yet been reported. Understanding the homeostatic flux of mHTT over time and under different processing conditions would aid in interpretation of pre-clinical assessments of disease interventions. OBJECTIVE: Provide a systematic evaluation of tissue lysis methods and molecular and biochemical assays in parallel with behavioral readouts in R6/2 mice to establish a baseline for HTT exon1 protein accumulation. METHODS: Established biochemical methods were used to process tissue from R6/2 mice of specific ages following behavior tasks. Aggregation states and accumulation of mHTT exon 1 protein were evaluated using multiple break and assay methods to determine potential conformational flux assay specificity in detection of mHTT species, and tissue specificity of conformers. RESULTS: Detection of mHTT exon 1 protein species varied based on biochemical processing and analysis providing a baseline for subsequent studies in R6/2 mice. Insoluble, high molecular weight species of mHTT exon 1 protein increased and tracked with onset of behavioral impairments in R6/2 mice using multiple assay methods. CONCLUSIONS: Conformational flux from soluble monomer to high molecular weight, insoluble species of mHTT exon 1 protein was generally consistent for multiple assay methods throughout R6/2 disease progression; however, the results support the use of multiple biochemical techniques to detect mHTT exon 1 protein species for preclinical assessments in HDmouse models expressing mHTT exon 1 protein.
Entities:
Keywords:
Huntingtin; Huntington’s disease; aggregation; conformer; protein aggregates; protein homeostasis
Authors: C A Gutekunst; S H Li; H Yi; J S Mulroy; S Kuemmerle; R Jones; D Rye; R J Ferrante; S M Hersch; X J Li Journal: J Neurosci Date: 1999-04-01 Impact factor: 6.167
Authors: L Mangiarini; K Sathasivam; M Seller; B Cozens; A Harper; C Hetherington; M Lawton; Y Trottier; H Lehrach; S W Davies; G P Bates Journal: Cell Date: 1996-11-01 Impact factor: 41.582
Authors: Joseph Ochaba; Tamás Lukacsovich; George Csikos; Shuqiu Zheng; Julia Margulis; Lisa Salazar; Kai Mao; Alice L Lau; Sylvia Y Yeung; Sandrine Humbert; Frédéric Saudou; Daniel J Klionsky; Steven Finkbeiner; Scott O Zeitlin; J Lawrence Marsh; David E Housman; Leslie M Thompson; Joan S Steffan Journal: Proc Natl Acad Sci U S A Date: 2014-11-10 Impact factor: 11.205
Authors: Justin Legleiter; Emily Mitchell; Gregor P Lotz; Ellen Sapp; Cheping Ng; Marian DiFiglia; Leslie M Thompson; Paul J Muchowski Journal: J Biol Chem Date: 2010-03-10 Impact factor: 5.157
Authors: S W Davies; M Turmaine; B A Cozens; M DiFiglia; A H Sharp; C A Ross; E Scherzinger; E E Wanker; L Mangiarini; G P Bates Journal: Cell Date: 1997-08-08 Impact factor: 41.582
Authors: Jason Miller; Montserrat Arrasate; Elizabeth Brooks; Clare Peters Libeu; Justin Legleiter; Danny Hatters; Jessica Curtis; Kenneth Cheung; Preethi Krishnan; Siddhartha Mitra; Kartika Widjaja; Benjamin A Shaby; Gregor P Lotz; Yvonne Newhouse; Emily J Mitchell; Alex Osmand; Michelle Gray; Vanitha Thulasiramin; Frédéric Saudou; Mark Segal; X William Yang; Eliezer Masliah; Leslie M Thompson; Paul J Muchowski; Karl H Weisgraber; Steven Finkbeiner Journal: Nat Chem Biol Date: 2011-10-30 Impact factor: 15.040
Authors: Jacqueline Gire O'Rourke; Jaclyn R Gareau; Joseph Ochaba; Wan Song; Tamás Raskó; David Reverter; John Lee; Alex Mas Monteys; Judit Pallos; Lisa Mee; Malini Vashishtha; Barbara L Apostol; Thomas Peter Nicholson; Katalin Illes; Ya-Zhen Zhu; Mary Dasso; Gillian P Bates; Marian Difiglia; Beverly Davidson; Erich E Wanker; J Lawrence Marsh; Christopher D Lima; Joan S Steffan; Leslie M Thompson Journal: Cell Rep Date: 2013-07-18 Impact factor: 9.423
Authors: Joshua D Crapser; Joseph Ochaba; Neelakshi Soni; Jack C Reidling; Leslie M Thompson; Kim N Green Journal: Brain Date: 2020-01-01 Impact factor: 13.501
Authors: Joseph Ochaba; Gianna Fote; Marketta Kachemov; Soe Thein; Sylvia Y Yeung; Alice L Lau; Sarah Hernandez; Ryan G Lim; Malcolm Casale; Michael J Neel; Edwin S Monuki; Jack Reidling; David E Housman; Leslie M Thompson; Joan S Steffan Journal: Proc Natl Acad Sci U S A Date: 2019-05-14 Impact factor: 11.205